Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, has just launched Oncology Performance Edge, a new strategic research service that helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources.
"The oncology market is significantly different from others, with unique challenges," said Denise Woltemath, senior consultant for specialty/bio at Health Strategies Group.
"It faces a rapidly changing selling environment, a professional audience with disparate needs, and distinct obstacles to measuring the value and effectiveness of sales representatives and support services. The goal of Oncology Performance Edge is to help companies successfully address these issues, stay ahead of emerging trends, and make optimal use of their resources, both now and in the future."
Oncology Performance Edge includes three offerings, plus access to Health Strategies Group oncology experts, who help clients apply the market intelligence to their businesses objectives. These offerings include:
Total Office Call - A guide to understanding the most effective methods and messages for communicating with all audiences who influence oncology brand performance, including nurses, reimbursement coordinators, office administrators, infusion center personnel, and staff at cancer treatment facilities. Total Office Call identifies which marketing and sales resources these decision-makers value most, their level of satisfaction with current offerings, and unmet needs or ineffectively deployed resources by the company.
"Total Office Call is about knowing all audiences who influence the prescribing of your oncology product, understanding what matters to each, and meeting each group's needs with relevant content and support," said Woltemath,.